Data Safety Monitoring Board (DSMB)
An independent committee of experts that monitors the safety data from a clinical trial while it is ongoing, with the authority to recommend stopping the trial if needed.
In Detail
A Data Safety Monitoring Board (DSMB), also called a Data Monitoring Committee (DMC), is an independent group of experts that oversees the safety and efficacy data of a clinical trial while it is still in progress. DSMB members typically include clinicians, statisticians, ethicists, and patient advocates who have no financial or professional relationship with the trial sponsor. Their primary responsibility is to protect the safety of trial participants by reviewing accumulating data at predefined intervals. The DSMB has access to unblinded data, they can see which participants are in the treatment group and which are in the control group, while the rest of the research team remains blinded. Based on their review, the DSMB can recommend continuing the trial as planned, modifying the protocol (such as changing the dose or adding safety monitoring), or stopping the trial early. A trial may be stopped early for two reasons: either the treatment is showing unacceptable safety risks (futility or harm), or the treatment is so clearly effective that it would be unethical to continue assigning participants to the control group (overwhelming benefit). DSMB oversight is required for most Phase 3 trials and is strongly recommended for Phase 2 trials. The existence of an independent DSMB is an important safeguard for participants and demonstrates that the trial has robust safety monitoring in place. The DSMB operates under a charter that defines their authority, meeting schedule, and statistical analysis plan.
Frequently Asked Questions
What does "Data Safety Monitoring Board (DSMB)" mean in clinical trials?
An independent committee of experts that monitors the safety data from a clinical trial while it is ongoing, with the authority to recommend stopping the trial if needed.
Why is "data safety monitoring board (dsmb)" important for patients?
Understanding data safety monitoring board (dsmb) helps patients and caregivers navigate clinical trial participation with confidence. It is part of the broader clinical research process that ensures treatments are safe and effective before reaching patients.
Related Terms
Adverse Event (AE)
Any undesirable medical occurrence in a clinical trial participant, whether or not it is caused by the treatment being studied.
Serious Adverse Event (SAE)
An adverse event that results in death, hospitalization, disability, a life-threatening situation, or a birth defect, requiring immediate reporting to regulators.
Institutional Review Board (IRB)
An independent ethics committee that reviews and approves clinical research involving human subjects to ensure participants' rights, safety, and welfare are protected.
Clinical Trial
A research study that tests a medical treatment, drug, device, or intervention in human volunteers to determine whether it is safe and effective.
this entity is one of the U.S. clinical trials and research registries concepts that recurs across this site. The definition above is the technical answer; the paragraphs below add the practical context for how the concept connects to the the NIH ClinicalTrials.gov registry data behind every per-entity page on the site.
In the the NIH ClinicalTrials.gov registry data, this concept shapes one or more of the fields that drive the per-entity grades and rankings on this site. The methodology page describes which fields feed into which output; this glossary entry documents the underlying term.
Source: ClinicalTrials.gov, 2026.